Company: CRAC
Filing Date: 2025-09-24
Form Type: S-1/A
Source: 0001213900-25-090802
Chunk: 16

Company: Crown Reserve Acquisition Corp. I
Filing Date: 2025-09-24
Form: S-1/A
Chunk 16
---
 ordinary shares described in this prospectus will take effect as a redemption of Class B ordinary shares and an issuance of Class A ordinary shares as a matter of Cayman Islands law. All references in this prospectus to our share dividends shall take effect as share capitalizations as a matter of Cayman Islands law. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. No fractional shares will be issued in connection with the exchange of Share Rights. Accordingly, you must hold Share Rights in multiples of 5 in order to receive Class A ordinary shares for all of your Share Rights upon closing of a business combination. Unless we tell you otherwise, the information in this prospectus assumes that the underwriters will not exercise their over -allotment option and the forfeiture by our sponsor of 562,500 founder shares. Our Company General We are a blank check company incorporated on April 29, 2025 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have generated no revenues to date and we do not expect that we will generate operating revenues at the earliest until we consummate our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. 2 Purpose Crown Reserve Acquisition Corp. I intends to identify and acquire a business within an industry or sector that complements the experience of our management team and can benefit from our operational expertise. We will have a generalist approach to industry sectors, but with particular emphasis on industries where we have core competencies and experiences, such as pharma, medical technology and medical equipment, and healthcare IT industries. However, we may pursue an initial business combination opportunity in any industry or sector (subject to certain limitations described in this prospectus). Our Leadership Our management team and board consist of seasoned industry executives that possess deep collective understanding of various industries, including the pharma, medical technology and medical equipment, and healthcare IT, as well as the evolution of these sectors and market opportunities. Management Team Prashant Patel(age: 51) serves as Chairman and Chief Executive Officer. Mr.Patel served as a director and president of TRxADE Health, Inc. (NASDAQ: MEDS) from